+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06863805

Study of Circulating Biomarkers Using Blood Tests in Adults with Advanced Thyroid Cancer Comparing Blood-Based Molecular Profiles to Tumor Tissue Analysis for Treatment Decisions

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-03-07

10

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on adults diagnosed with advanced thyroid carcinomas, including well-differentiated iodine-refractory metastatic thyroid carcinomas, who are candidates for systemic therapy. The study evaluates the use of liquid biopsy, a noninvasive blood test analyzing circulating free DNA ccf-DNA, circulating free RNA ccf-RNA, and circulating tumor cells CTCs, to obtain molecular profiles similar to those from tumor tissue genomic sequencing. This approach aims to improve therapeutic choices for patients with advanced thyroid cancer. Participants will have blood samples collected at multiple points before starting systemic treatment, and at 1 month, 3 months, 6 months, and upon disease progression within 24 months after treatment initiation. These samples will undergo multigenic analysis of ccf-DNA and ccf-RNA, along with counting and analysis of CTCs. The study compares these liquid biopsy results with existing tumor tissue profiles to identify gene alterations and explore markers predicting treatment response and disease evolution. During the study, participants will undergo scheduled blood collections alongside routine laboratory visits. Researchers will measure gene alterations, metabolic response by FDG CT-PET, overall response rate, progression-free survival, tumor burden, and circulating tumor cell count and phenotype. The study is observational and aims to monitor these outcomes over about 24 months to assess the clinical utility of circulating biomarkers in guiding systemic therapy for advanced thyroid carcinomas.

CONDITIONS

Brief Title

Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas

Research Team

M

Margherita Nannini

M

Maria Abbondanza Pantaleo

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here